Efficacy and Safety Study of Neramexane to Treat Congenital and Acquired Nystagmus

Clinical trial NCT00661440 · COMPLETED

Trial details

NCT number: NCT00661440
Sponsor: Merz Pharmaceuticals GmbH
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Nystagmus, Congenital Idiopathic Nystagmus, Acquired

Start date: 2008-05-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.